연구동향 분석

Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases

Wei-Rong Chen Jia-Peng Deng Jun Wang Jia-Yuan Sun Zhen-Yu He San-Gang Wu 2019년

논문상세정보
인용/피인용
' Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Breast neoplasms
  • Drug therapy
  • surgery
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
675 0

0.0%

' Impact of 21-Gene Recurrence Score on Chemotherapy Decision in Invasive Ductal Carcinoma of Breast with Nodal Micrometastases' 의 참고문헌

  • Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer : American Society of Clinical Oncology Clinical Practice Guideline Focused Update
    Krop I [2017]
  • Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2– node positive breast cancer-A National Cancer Database study
  • The value of comparative effectiveness research : projected return on investment of the RxPONDER trial(SWOG S1007)
    Wong WB [2012]
  • The impact of nodal micrometastasis on mortality among women with early-stage breast cancer
    Iqbal J [2017]
  • Surveillance, Epidemiology, and End Results (SEER) Program. Oncotype DX database (2004-2015)
  • Stage migration due to introduction of the sentinel node procedure : a population-based study
    Maaskant AJ [2009]
  • Sentinel lymph node micrometastasis in human breast cancer: an update
    Salhab M [2011]
  • Role of patient and disease factors in adjuvant systemic therapy decision making for earlystage, operable breast cancer : American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations
    Henry NL [2016]
  • Race-associated biological differences among Luminal A breast tumors
  • Prospective validation of a 21-gene expression assay in breast cancer
    Sparano JA [2015]
  • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy : a retrospective analysis of a randomised trial
    Albain KS [2010]
  • Post-mastectomy radiation therapy in breast cancer patients with nodal micrometastases
    Wu SP [2018]
  • Personalized therapy for breast cancer
    De Abreu FB [2014]
  • Personalized medicine : present and future of breast cancer management
    Sabatier R [2014]
  • NCCN clinical Practice guidelines in oncology V.2.2018. Breast Cancer, Plymouth Meeting
  • Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure
    Montagna E [2009]
  • Micrometastases or isolated tumor cells and the outcome of breast cancer
    de Boer M [2009]
  • Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes
    Andersson Y [2018]
  • Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort
    Forissier V [2017]
  • Introduction of sentinel node biopsy and stage migration of breast cancer
  • Impact of micrometastases in the sentinel node of patients with invasive breast cancer
    Hansen NM [2009]
  • Gene expression and benefit of chemotherapy in women with nodenegative, estrogen receptor-positive breast cancer
    Paik S [2006]
  • Decline in the use of anthracyclines for breast cancer
    Giordano SH [2012]
  • Comparison of SEER treatment data with medicare claims
    Noone AM [2016]
  • Clinical outcomes in ER+ HER2-node-positive breast cancer patients who were treated according to the Recurrence Score results : evidence from a large prospectively designed registry
    Stemmer SM [2017]
  • Axillary recurrence rate in breast cancer patients with negative sentinel lymph node(SLN)or SLN micrometastases : prospective analysis of 150 patients after SLN biopsy
    Langer I [2005]
  • Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
    Sparano JA [2018]
  • A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer
    Frazier TG [2015]
  • 21-Gene recurrence score assay predicts benefit of post-mastectomy radiotherapy in T1-2 N1 breast cancer
    Goodman CR [2018]
  • 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer